Coronavirus live | Novavax starts shipping COVID-19 vaccines to EU states
The Hindu
The cumulative number of COVID-19 vaccine doses administered in the country crossed 176.47 crore on Wednesday, the Union health ministry said
Prioritisation of population groups, procurement strategies, pricing, cold-chain management, and issues of logistics was some of the questions the Government of India needed to tackle for the success of the COVID-19 vaccination journey said a set of two reports – ‘COVID-19-India’s Vaccine Development Story’ and ‘India’s COVID-19 Vaccination Administration Journey’ — released by Union Health Minister Mansukh Mandaviya on Wednesday.
You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.
Here are the latest updates
Drugmakers Sanofi and GlaxoSmithKline said Wednesday they will seek regulatory approval for a new COVID-19 vaccine after human trials showed it provided a high level of protection against the disease.
Late-stage trials found that two doses of the vaccine were about 58% effective in preventing infection and 75% effective in preventing moderate to severe disease, the companies said in a statement. A separate study on the vaccine’s use as a booster showed that it “induced a significant increase in neutralizing antibodies,’‘ they said. -AP
AstraZeneca plc signed an agreement with Canada for 100,000 doses of its antibody therapy for prevention of COVID-19 in some high-risk patients, the country’s government said on Wednesday.
AstraZeneca’s Evusheld is under review by Health Canada for use as a preventive treatment against the disease in those who are immunocompromised. - Reuters